NASDAQ · QSI

Quantum – Si Incorporated

$0.78 +$0.01 (+1.73%) 1D Pre-market
Session Pulse Pre-market 1 mentions on Fri No new SEC filings since Mon close its sector ranked 9/11 this week Full pulse →

Key Metrics

$167.70M
Market cap
P/E · TTM
$1.85M
Revenue · TTM
−$103.82M
Net income
EPS · TTM $-0.57
Dividend yield
Free cash flow −$95.69M
Beta · 1Y 3.52
EBITDA · TTM −$99.13M
Gross margin 40.0%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 24
    A material event was filed (Form 8-K).

    8-K - Quantum-Si Inc (0001816431) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 24
    From its Jun 4 high, the share price fell 40%.

    Peak close $1.28 on Jun 4; trough close $0.77 on Jul 24. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -40%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 5
    The stock moved -18.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 5
  • Apr 15
    The stock moved +24.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 15

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$167.70M
Enterprise value
Shares outstanding217.8M
52-wk range$0.69 – $3.10
Avg volume · 20D4.2M
Net cash
Book value / share$1.10
IndustryMeasuring & Controlling Devices, Nec
ExchangeNASDAQ
About Quantum – Si Incorporated
IPO dateJun 11, 2021
Employees145

Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S90.55
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 40.0%
Operating -5,609.9%
Net -5,605.9%
FCF -5,166.8%
ROE / ROIC -49.9% · -141.4%

Financial Health

Current ratio12.60
Quick ratio12.40
Debt / equity
Debt / EBITDA
Net cash
Working capital$124.26M

Cash Flow · TTM

Operating CF −$94.20M
Capex −$1.49M
Free cash flow −$95.69M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

2.4
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings